Roche Holding AG (OTCMKTS:RHHVF – Get Free Report)’s stock price was down 3.3% during trading on Thursday . The stock traded as low as $433.37 and last traded at $449.03. Approximately 87,761 shares traded hands during mid-day trading, an increase of 185% from the average daily volume of 30,797 shares. The stock had previously closed at $464.19.
Roche Trading Down 2.2%
The business’s 50-day moving average price is $448.23 and its 200 day moving average price is $388.49.
Roche Company Profile
Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.
In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.
Featured Stories
- Five stocks we like better than Roche
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
